Neuranix announces a new completed capital injection and a reinforced shareholder structure

We are proud to announce that after a long period of intense R&D, product testing and the launch of our first PLAI™ based devices in the veterinary field, Neuranix has now laid the basis for the future with a new 2.1 million Euros capital increase round to back the further development of new products in the human ENT field and to support the business development efforts in the veterinary field. For more information please enjoy reading the following press release.

Informazioni societarie

Capitale sociale 18.813,99 € non I.V.

Company Info

Social capital 18.813,99 € not I.V.